{"article_link": "https://doi.org/10.1038/s41586-021-04278-5", "data": [{"id": "data_1", "omics": "Genomics", "link": "https://ega.ebi.ac.uk/", "format": "Processed Data", "source": "European Genome-Phenome Archive (EGA)", "public_id": "EGAS00001004582"}, {"id": "data_2", "omics": "Transcriptomics", "link": "https://ega.ebi.ac.uk/", "format": "Processed Data", "source": "European Genome-Phenome Archive (EGA)", "public_id": "EGAS00001004582"}, {"id": "data_3", "omics": "Digital Pathology", "link": "", "format": "Processed Data", "source": "Cambridge University Hospitals NHS Foundation Trust (internal data)", "public_id": ""}], "analyses": [{"id": "analysis_1", "analysis_type": "Differential RNA Expression Analysis", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"], "gene_expression_levels": "pCR vs. Residual Disease"}}, {"id": "analysis_2", "analysis_type": "Gene Set Enrichment Analysis", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"Response": ["pCR", "Residual Disease"]}}, {"id": "analysis_3", "analysis_type": "Copy Number Calling", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"RCB_class": ["pCR", "RCB-I", "RCB-II", "RCB-III"], "ordinal_mapping": "pCR > RCB-I > RCB-II > RCB-III"}}, {"id": "analysis_4", "analysis_type": "Mutational Signature Decomposition", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"Signatures": ["HRD", "APOBEC"], "Response": ["pCR", "Residual Disease"]}}, {"id": "analysis_5", "analysis_type": "HLA Typing and Neoantigen Calling", "analysis_data": ["data_1", "data_2"], "training_set": [], "test_set": [], "label": {"Neoantigen_Load": ["high", "low"], "HLA_LOH_Status": ["present", "absent"], "Response": ["pCR", "Residual Disease"]}}, {"id": "analysis_6", "analysis_type": "Genomic and Transcriptomic-Based iC10 Classification", "analysis_data": ["data_1", "data_2"], "training_set": [], "test_set": [], "label": {"iC10_Subtype": ["iC1", "iC2", "iC3", "iC4", "iC5", "iC6", "iC7", "iC8", "iC9", "iC10"], "RCB_Class": ["pCR", "RCB-I", "RCB-II", "RCB-III"]}}, {"id": "analysis_7", "analysis_type": "Multi-Omic Machine Learning Model for Predicting Pathological Complete Response", "analysis_data": ["data_1", "data_2", "data_3"], "training_set": [], "test_set": [], "label": {"RCB_Class": ["pCR", "RCB-I", "RCB-II", "RCB-III"], "ordinal_mapping": "pCR > RCB-I > RCB-II > RCB-III"}}], "results": [{"analysis_id": "analysis_1", "metric": "Fold Change", "value": "2,071 genes underexpressed (FDR < 0.05) and 2,439 genes overexpressed (FDR < 0.05)", "features": ["CDKN2A", "EGFR", "CCNE1", "MYC", "CCND1", "ZNF703", "ESR1"]}, {"analysis_id": "analysis_2", "metric": "Normalized Enrichment Score", "value": "Proliferation: 2.0 (FDR < 0.05), Immune activation: 1.8 (FDR < 0.05)", "features": ["Proliferation (Hallmarks: G1 to S Phase Transition, E2F Targets)", "Immune activation (Hallmarks: IFNα/γ Response, TNF Signaling, Cytolytic Activity)"]}, {"analysis_id": "analysis_3", "metric": "Monotonic Association", "value": "Copy number alterations increased from 10% in pCR to 30% in RCB-III (P=0.0002, ordinal logistic regression)", "features": ["Copy number alterations", "Chromosomal instability"]}, {"analysis_id": "analysis_4", "metric": "Monotonic Association", "value": "HRD score increased from 2.0 in pCR to 3.5 in RCB-III (P=0.00001, ordinal logistic regression)", "features": ["HRD score (Telomeric Allelic Imbalance, LOH, Large-Scale Transitions)", "APOBEC signature (normalized exposure)"]}, {"analysis_id": "analysis_5", "metric": "Binding Affinity", "value": "Neoantigens with binding affinity score < 500 nM and HLA LOH status", "features": ["HLA A*02:01", "Neoantigens with high binding affinity", "HLA LOH status"]}, {"analysis_id": "analysis_6", "metric": "Overrepresentation", "value": "iC10 subtype iC10 overrepresented in pCR cases (Pearson residual: +2.0), iC3 underrepresented (-1.5)", "features": ["iC10 Subtype"]}, {"analysis_id": "analysis_7", "metric": "AUC", "value": "0.87 in external validation (75 patients), with AUCs of 0.70 (clinical), 0.80 (clinical + DNA), 0.86 (clinical + RNA), 0.85 (clinical + DNA + RNA + digital pathology), and 0.87 (fully integrated model)", "features": {"clinical_features": ["Age", "ER Status", "HER2 Status", "Histological Grade"], "genomic_features": ["TP53 Mutation Status", "Copy Number Alterations", "HRD Score", "Neoantigen Load", "HLA LOH"], "transcriptomic_features": ["PGR Expression", "ESR1 Expression", "ERBB2 Expression", "GGI Score", "STAT1 Score"], "digital_pathology_features": ["Lymphocyte Density"]}}]}